Transaction Will Maximize the Access and Uptake of COSELA® (trilaciclib), the First and Only Proactive Multilineage ...

Trilaciclib is under clinical development by G1 Therapeutics and currently in Phase III for Triple-Negative Breast Cancer (TNBC).

The proposed Human Genome Project II could set in motion a 'paradigm shift' toward more precise public health, and a global research alliance A group of Chinese researchers has launched an ...

Researchers from the University of Alabama at Birmingham have identified a promising new combination therapy for metastatic ...

This, in turn, prompts the downregulation of cyclin D2 and the upregulation of the p27kip1 protein, eventually leading to cell cycle arrest at the G1 phase. In terms of angiogenesis, HGF stimulates ...

Anifrolumab is under clinical development by AstraZeneca and currently in Phase II for Hidradenitis Suppurativa.

Shares in iTeos Therapeutics dropped over 20% despite positive interim data from the GALAXIES Lung-201 Phase II study with ...

The Illinois Racing Board has approved the acquisition of FanDuel Sportsbook and Horse Racing, the former Fairmount Park, by ...

First growth phase in the eukaryotic cell cycle From Wikipedia, the free encyclopedia ...

Here we show that the cell-cycle regulator p21 is involved in immune system function. T lymphocytes from p21 −/− mice exhibit significant proliferative advantage over wild-type cells following ...